Cognitive Neurologist Professor Peter Nestor has been appointed to the position of Clinical Program Leader of the Neurosciences and Cognitive Health Program at Mater.

Simulation is a valuable tool used to educate and train health professionals. Where simulation involves models that are intended to replicate clinical or technical tasks, there are gaps in our...

Mater congratulates the four Mater People recognised in this year’s Australia Day Honours list.

Professor Vicki Flenady and her team at the Stillbirth Centre of Research Excellence (CRE) at Mater Research Institute – University of Queensland were awarded the UQ Faculty of Medicine...

Join the Miles for Miracles: Japan Trek 2019 and help give the best possible start to life for all babies born and cared for at Mater.

Dr Peter Steer has commenced his appointment as Mater Group Chief Executive Officer.

The 2017/2018 Mater Annual Review is now available online.

Researchers from Mater Research have been awarded more than $1.84 million in National Health and Medical Research Council (NHMRC) funding.

Mater Group is proud to mark a milestone in its history, the launch of a new brand, to reposition Mater as a group incorporating health, education and research for a healthy community.

A Mater researcher has developed a method to predict breast cancer patient responses to a commonly prescribed breast cancer drug.

A new mobile phone app being trialled at Mater Mothers’ Hospital Brisbane aims to reduce the rate of stillbirth in Australia by 30 per cent by focusing on a baby’s kicks.

A new triple-combination drug trialled at Mater in Brisbane could increase the life expectancy of patients with cystic fibrosis (CF).